1ACHC Stock Chart & Stats
€24.60
-€0.60(-2.16%)
At close: 4:00 PM EDT
€24.60
-€0.60(-2.16%)
Day’s Range― - ―
52-Week Range€6.00 - €46.00
Previous CloseN/A
Volume0.00
Average Volume (3M)4.00
Market Cap
€2.61B
Enterprise Value€5.30B
Total Cash (Recent Filing)€171.29M
Total Debt (Recent Filing)€2.56B
Price to Earnings (P/E)―
Beta0.32
Next Earnings
Nov 04, 2026EPS Estimate
0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.45
Shares Outstanding93,100,270
10 Day Avg. Volume3
30 Day Avg. Volume4
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.66
Price to Sales (P/S)0.39
P/FCF Ratio-2.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€31.99Price Target Upside30.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)1.36
Revenue Forecast (FY)€3.05B
Bulls Say, Bears Say
Bulls Say
Capacity ExpansionPlanned bed additions and new joint-venture facilities expand Acadia’s revenue capacity in a growing behavioral-health network. New cohorts are outperforming start-up targets, suggesting disciplined execution and a pathway for recently added assets to contribute increasingly attractive earnings.
Cash Flow And Debt ReductionStrong quarterly free cash flow and substantial debt repayment demonstrate improving internal funding capacity despite recent volatility. Continued cash conversion would strengthen liquidity, reduce leverage, and give Acadia more flexibility to support facility growth without relying as heavily on external financing.
Broad Behavioral Health PlatformA broad care continuum allows Acadia to serve patients across inpatient, residential, specialty, and outpatient settings rather than relying on one treatment format. That network structure supports referrals and step-down care while creating multiple avenues for sustained patient-service revenue.
Bears Say
Profitability DeteriorationThe sharp swing from profitability to a large TTM net loss indicates that current earnings power is weak and volatile. Revenue contraction compounds the issue, making it harder for operating leverage to emerge and increasing the importance of successful facility ramps and cost control.
Leverage And Free Cash Flow PressureHigher leverage reduces financial flexibility at a time when free cash flow has not yet converted consistently from operating cash generation. This can constrain capital allocation, increase dependence on financing, and leave less capacity to absorb operating setbacks or prolonged earnings weakness.
Rising Professional Liability CostsThe higher liability-cost outlook creates a recurring pressure on margins and makes earnings less predictable. Management also said additional actuarial adjustments are difficult to predict, so reserve volatility could continue to offset operating gains and weaken confidence in sustainable profitability.
Acadia Healthcare News
1ACHC FAQ
What was Acadia Healthcare’s price range in the past 12 months?
Acadia Healthcare lowest stock price was €6.00 and its highest was €46.00 in the past 12 months.
What is Acadia Healthcare’s market cap?
Acadia Healthcare’s market cap is €2.61B.
When is Acadia Healthcare’s upcoming earnings report date?
Acadia Healthcare’s upcoming earnings report date is Nov 04, 2026 which is in 7 days.
How were Acadia Healthcare’s earnings last quarter?
Acadia Healthcare released its earnings results on Jul 28, 2026. The company reported €0.34 earnings per share for the quarter, beating the consensus estimate of €0.31 by €0.03.
Is Acadia Healthcare overvalued?
According to Wall Street analysts Acadia Healthcare’s price is currently Undervalued.
Does Acadia Healthcare pay dividends?
Acadia Healthcare does not currently pay dividends.
What is Acadia Healthcare’s EPS estimate?
Acadia Healthcare’s EPS estimate is 0.41.
How many shares outstanding does Acadia Healthcare have?
Acadia Healthcare has 93,100,270 shares outstanding.
What happened to Acadia Healthcare’s price movement after its last earnings report?
Acadia Healthcare reported an EPS of €0.34 in its last earnings report, beating expectations of €0.31. Following the earnings report the stock price went down -13.986%.
Which hedge fund is a major shareholder of Acadia Healthcare?
Currently, no hedge funds are holding shares in IT:1ACHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Acadia Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€31.99 (30.04% Upside)
€31.99 (30.04% Upside)
Blogger Sentiment
Bullish
IT:1ACHC Sentiment 71%
Sector Average 66%
Sector Average 66%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.01%
12-Months-Change
Fundamentals
Return on Equity
-50.02%
Trailing 12-Months
Asset Growth
-12.08%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Acadia Healthcare
Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico. Patients receive care in diverse environments, including acute inpatient psychiatric hospitals, specialized treatment facilities, long-term residential centers, and outpatient clinics. As of March 31, 2022, the company managed an extensive network consisting of 238 behavioral healthcare facilities, collectively providing approximately 10,600 beds. Established in 2005, Acadia Healthcare is headquartered in Franklin, Tennessee.
1ACHC Company Deck
1ACHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was predominantly positive: management reported results at or above guidance, strong free cash flow, substantial debt reduction, improving performance from new facilities, operational gains, and confidence in the full-year outlook. Offsetting issues included flat reported revenue, the impact of New York Medicaid changes, a significant professional liability reserve adjustment, CTC performance below expectations, start-up losses, and uncertainty around government investigation costs. The highlights significantly outweighed the lowlights.View all IT:1ACHC earnings summaries1ACHC Stock 12 Month Forecast
Average Price Target
€31.99
▲(30.04% Upside)
Technical Analysis
Community Health
―
HCA Healthcare
―
Healthcare Services
―
Universal Health
―
Lifestance Health Group
―